The synthesis and microbiological evaluation of 7-, 8-and 9-nitro-1,2,4-trihalogenophenoxazin-3-one substrates with potential in the detection of nitroreductaseexpressing pathogenic microorganisms are described. The 7-and 9-nitrotrihalogenophenoxazinone substrates were reduced by most Gram negative microorganisms and were inhibitory to the growth of certain Gram positive bacteria; however, the majority of Gram positive strains that were not inhibited by these agents, along with the two yeast strains evaluated, did not reduce the substrates. These observations suggest there are differences in the active site structures and substrate requirements of the nitroreductase enzymes from different strains; such differences may be exploited in the future for differentiation between pathogenic microorganisms. The absence of reduction of the 8-nitrotrihalogenophenoxazinone substrates is rationalized according to their electronic properties and correlates well with previous findings.
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Introduction
The ability of nitroreductase and other enzymes to reduce an aromatic nitro group to the corresponding hydroxylamine and/or amine is of significant interest, with great potential for biomedical, biocatalyst and bioremediation applications. [1] [2] [3] [4] For example, the reduction of a nitroaromatic prodrug by a bacterial nitroreductase is central to the GDEPT anticancer therapeutic approach, 5, 6 for which the mechanism of the Escherichia coli nitroreductase activation has been elucidated. 7 Nitroreductase enzymes have been subdivided into two different classes, 8, 9 namely type I and type II nitroreductases, based on their relative sensitivity to oxygen. The type I nitroreductases are oxygen insensitive and can reduce nitro compounds to their corresponding amines via the nitroso and hydroxylamine intermediates, using a two electron transfer mechanism. [9] [10] [11] With the type II nitroreductases, which are oxygen sensitive, the reduction of nitro groups is initiated via a single electron transfer process, forming a nitro radical anion, which either accepts a second electron to form the nitroso intermediate and then follows the two electron reduction process, or is rapidly reoxidised to a nitro group in the presence of oxygen. 8, 9 The widespread distribution of nitroreductase enzymes in pathogenic bacteria and yeasts offers the potential to enhance the detection of such microorganisms in both clinical and food applications. 11, 12 The successful detection of pathogenic bacteria as a result of their nitroreductase action has been demonstrated in over thirty Gram negative and Gram positive microorganisms, 11 using the fluorogenic 7-nitrocoumarin-3-carboxylic acid 1a or 7-nitro-4-methylcoumarin 1b (Figure 1) . These compounds emit a strong fluorescent signal upon exposure to U.V. light (λ = 365nm) after incubation with the bacteria. Moreover, other fluorogenic compounds, such as the 4-nitrobenzylcarbamate derivatives of 7-aminocoumarins, 13 and derivatives of nitrobenzoxazole 2a, nitrobenzothiazole 2b and nitrobenzimidazole 2c (Figure 1 ), were also shown to respond to nitroreductase activity, although with greater selectivity for Gram negative bacteria. 14, 15 The extension of this approach to chromogenic nitroaromatic substrates, including derivatives of 4-(4'-nitrostyryl)-pyridine 3a, 16 4-(4'-nitrostyryl)-quinoline 3b 17 and 2-(4'-nitrostyryl)-benzothiazole 3c 18 ( Figure 1) , suggests a general application of nitroreductase enzyme substrates as detection agents, particularly for Gram negative pathogenic bacteria. It is interesting to note that more spatially compact nitroreductase substrates, such as nitrobenzenes and nitrocoumarins 1a and 1b, 11, 13 are reduced by a wider range of both Gram negative and Gram positive bacteria, while the more bulky nitroaromatic substrates, for example, the nitrobenzoxazole 2a, nitrobenzothiazole 2b and nitrobenzimidazole 2c derivatives, are less well reduced by the Gram positive bacteria, [14] [15] [16] [17] [18] which may suggest differences in the active sites of Gram negative nitroreductases compared to those of Gram positive bacteria. We previously reported the synthesis and the microbiological evaluation of the chromogenic 7-aminophenoxazinones 4 and their corresponding aminopeptidase substrates, which indicate the presence of certain bacteria by the intense colour released upon bacterial enzymatic action. 19 By analogy, the corresponding 7-nitrophenoxazinone was a desirable target substrate as a potential marker of nitroreductase activity. Herein we report the preparation and evaluation of 7-, 8-and 9-nitro-1,2,4-trihalogenophenoxazin-3-ones 5-7, (Figure 2) , for their ability to detect pathogenic microorganisms through nitroreductase activity. 
Results and discussion

Synthesis
The nitrotrihalogenophenoxazinones were synthesized using the route described previously for the synthesis of 7-nitrohalogenophenoxazinones 5b, 5c and 8-nitro-1,2,4-trichlorophenoxazinone 6b 20 without modification. With the availability of several 2-aminonitrophenol isomers, the opportunity was taken to include the synthesis of 8-nitro and 9-nitrophenoxazinones in this study. Following the general procedure, 2-aminonitrophenols 8-10 were condensed with tetrahalogeno-1,4-benzoquinones 11a-c in an ethanolic solution containing sodium acetate (Scheme 1). 7-Nitro 5a-c, 8-nitro 6a-c and 9-nitro-1,2,4-trihalogenophenoxazin-3-ones 7a,b were isolated in low to high yield ( Table 1) . The formation of the desired products was confirmed mostly by 13 C NMR spectroscopy, with the characteristic C-F coupling observed in the 13 C NMR spectra of fluorinated nitrophenoxazin-3-ones 5a, 6a and 7a assisting the characterization of these novel products. The synthesis of fluorinated derivatives 5a, 6a and 7a proved to be problematic and all were isolated in poor yield, along with a highly insoluble solid, suspected to be triphenodioxazines 12a-c, respectively. Spectroscopic evidence for structure 12a was obtained alongside nitrophenoxazinone 5a. Mital and Jain have described the formation of triphenodioxazines under conditions similar to those described here (Scheme 1).
21
A reaction mechanism for an analogous condensation of various aminophenols with 2,3-dichloro-1,4-naphthoquinone in an ethanolic solution containing sodium or potassium acetate has been reported by Agarwal and Schäfer. 22 Deprotonation of the nitroaminophenol 8-10 is followed by a 1,4-Michael-type nucleophilic attack of the resulting phenoxide on 
Microbiological evaluation
The chromogenic substrates 5-7 were evaluated for their suitability as nitroreductase substrates for the detection of microbial nitroreductase activity. The reduction of the weakly coloured compounds 5-7 by an unspecified nitroreductase was expected to produce the corresponding, intensely coloured, aminophenoxazin-3-ones 16a-c, 17a-c and 18a,b. This would result in a dramatic and readily visualised change in colour at the site of reduction (Scheme 3). None of the substrates were toxic to the Gram negative bacteria and growth was observed in the presence of all substrates; however, toxicity was observed towards some of the Gram positive bacteria and yeasts, resulting in the inhibition of the growth of these organisms. The most toxic substrate was 8-nitro-1,2,4-trifluorophenoxazin-3-one 6a, which was universally toxic to all Gram positive bacteria and the yeasts, while 9-nitro-1,2,4-trifluorophenoxazin-3-one 7a was toxic to most of these strains and 7-nitro-1,2,4-trifluorophenoxazin-3-one 5a also (No. 14); of these three strains, only MRSA was not inhibited by substrates 5b, 5c and 7b.
Although few of the Gram positive bacteria and the yeasts were unable to reduce the nitro substrates, it was not due to a lack of expression of nitroreductase, as it has been previously shown that they reduce other nitroreductase substrates.
11
The three 8-nitrophenoxazinone substrates 6a-c were not reduced by nitroreductases from Gram negative bacteria, unlike their analogues 5a-c and 7a,b, despite good bacterial growth ( Table 2) . Catalytic reduction of the 8-nitrophenoxazinones 6a-c using hydrogen and either Pd/C or PtO 2 , followed by re-oxidation of the initial aminophenol product (19a-c) with manganese (IV) oxide, produced deeply coloured 8-aminophenoxazinones (17a-c), of which the most soluble example, 1,2,4-trifluoro-8-aminophenoxazin-3-one 17a, was isolated and characterized (Scheme 4). The lack of any colour after incubation of the 8-nitrophenoxazinones 6a-c with bacteria thus provides evidence that the three compounds were not substrates for nitroreductase activity. Early work by McCormick 28 and later studies by Kitamura, 29 testing a wide range of variously substituted nitrocompounds for their suitability as nitroreductase substrates, showed that the position of the nitro group with respect to other substituents, alongside their electronic properties, is a determining factor in the bacterial reduction of nitroaromatic compounds. For example, nitroreductase activity was generally higher for nitrobenzenes bearing a paraelectron withdrawing group. Consideration of the substituents at the para-position to the nitro group in each of the present substrates reveals that compounds 5a-c, with the nitro group in the 7-position, have the electron withdrawing quinone-imine system in the para-position. In compounds 7a,b, the 9-nitro group is conjugated at the ortho-position to the quinone-imine system and C9 may be considered to be similarly electron deficient to C7 in 5a-c. Conversely, in compounds 6a-c, the 8-nitro group is para to the potentially electron releasing ether oxygen. Overall then, the electron density at C8 in the case of substrates 6a-c can be expected to be considerably higher than C7 and C9 in the case of substrates 5a-c and 7a,b, respectively.
The electron withdrawing effect of the quinone-imine portion of the phenoxazinone ring affects the 7-and 9-positions primarily and would thus be expected to facilitate the reduction of substrates 5 and 7 (Scheme 5), the oxygen bridging atom can contribute to some extent to the higher electron density at the 8-position, thereby reducing the propensity for reduction of substrates 6a-c (Scheme 5).
Scheme 5. Key resonance forms that contribute to differentiation of nitroreductase activity in (a) 7-nitrohalogenophenoxazin-3-ones 5a-c, and (b) 8-nitrohalogenophenoxazin-3-ones 6a-c
The 13 C NMR data provide support for these electronic differences ( Table 3) : in compounds 5a-c and 7a,b, the chemical shifts of C7 and C9, respectively, show greater deshielding than C8 of the corresponding halogenated compounds 6a-c. Table 3 . 13 C NMR data for C-NO 2 of nitrotrihalogenophenoxazin-3-ones 5a-c, 6a-c, and 7a,b
Chemical shift of C bearing nitro group (d 6 -DMSO; δ / ppm) These observations correlate well with Kitamura's experiments 29 and help to explain the absence of visible reduction for substrates 6a-c, while substrates 5a-c and 7a,b were reduced to some extent.
Conclusions
Although some substrate selectivity has been previously observed with the nitroreductase from the food and gastrointestinal bacterium, Lactobacillus plantarum 30 , the differences in the reduction of the substrates, particularly by the bacteria used in the current work, suggest that, rather than detecting a wide range of Gram negative and Gram positive microorganisms, nitroreductase activity on substituted 7-or 9-nitrophenoxazinones could be used to distinguish certain pathogenic strains. Furthermore, differences in the nitroreductase enzymes, or in the nitro group metabolic pathways, between strains can be inferred by the variations in reduction of a particular nitroaromatic substrate.
The 8-nitro-1,2,4-trihalogenophenoxazin-3-ones 6a-c proved to be unsuitable for the detection of bacterial nitroreductase; the electronic factors associated with the position of the 8-nitro group on the phenoxazin-3-one ring appear to be very unfavourable for enzymatic reduction.
These observations correlate with results previously published. 
Experimental section
General methods
All commercially available reagents and solvents were obtained from Sigma-Aldrich, Fluka or Riedel-de-Haan and were used without further purification. Melting points were recorded on a Reichart-Kofler hot-stage microscope apparatus and are uncorrected. Infrared spectra were recorded in the range 4000 -600 cm -1 using a Perkin Elmer Spectrum BX FT-IR instrument with internal calibration and a Pike sampling system. NMR spectra were obtained using a Bruker Ultrashield 300 spectrometer at 300 MHz for 1 H spectra, 75 MHz for 13 C spectra or at 282 MHz for 19 F spectra or a Bruker Ultrashield 500 spectrometer at 500 MHz for 1 H spectra or at 125 MHz for 13 C spectra. High-resolution mass spectra were obtained from the EPSRC National Mass Spectrometry Facility Swansea, using a Thermofisher LTQ Orbitrap XL. Elemental analyses were performed using an Exeter Analytical CE-440
Elemental Analyzer. 
Synthesis of nitrohalogenophenoxazin-3-ones
7-Nitro-1,2,4-trifluoro-3H-phenoxazin-3-one (5a) and 3,10-dinitro-6,13-difluorotriphenodioxazine (12a). The title compounds were prepared from p-fluoranil 11a
(1.90 g, 10.57 mmol) and 2-amino-5-nitrophenol 8 (1.42 g, 9.61 mmol) according to the general procedure. Water (100 mL) was added to the reaction mixture and the resulting mixture was extracted with EtOAc (3 × 60 mL). The emulsion was filtered through a sintered funnel and the insoluble residue was washed several times with EtOAc, giving 12a as a dark 103.2 (quat., 4-C), 112.5 (CH, 6-C), 121.4 (CH, 8-C), 131.9 (CH, 9-C), 134.9 (quat., 1-C or 2-C), 137.0 (quat., 1-C or 2-C), 137.1 (quat., 5a-C), 143.6 (quat., 9a-C), 147.2 (quat., 4a-C or 10a-C), 148.3 (quat., 4a-C or 10a-C), 149.7 (7-C), 171.5 (quat., 3-C). 
7-Nitro-1,2,4-trichloro-3H-phenoxazin-3-one (5b
7-Nitro-1,2,4-tribromo-3H-phenoxazin-3-one (5c
8-Nitro-1,2,4-trifluoro-3H-phenoxazin-3-one (6a)
.
8-Nitro-1,2,4-trichloro-3H-phenoxazin-3-one (6b)
. 21 The title compound was prepared from p-chloranil 11b (1.74 g, 7.07 mmol) and 2-amino-4-nitrophenol 9 (0.991 g, 6.43 mmol);
6b was isolated as a red solid (2.19 g, 6.34 mmol, 99% (CH, 6-C), 125.9 (CH, 9-C), 129.1 (CH, 7-C), 132.6 (quat., 9a-C), 137.2 (quat., 1-C or 2-C),
138.2 (quat., 1-C or 2-C), 145.3 (quat., 8-C), 145.6 (quat., 4a-C or 10a-C), 146.2 (quat., 4a-C or 10a-C), 147.7 (quat., 5a-C), 171.1 quat., 3-C). , 9a-C), 134.6 (CH, 7-C), 136.9 (quat., 1-C or 2-C), 138.6 (quat., 1-C or 2-C), 143.7 (quat., 5a-C), 145.5 (quat., 4a-C or 10a-C), 146.3 (quat., 4a-C or 10a-C), 147.8 (quat., 9-C), 171.0 (quat., 3-C).
8-Nitro-1,2,4-tribromo-3H-phenoxazin-3-one (6c
9-Nitro-1,2,4-trifluoro-3H-phenoxazin-3-one (7a)
9-Nitro-1,2,4-trichloro-3H-phenoxazin-3-one (7b
Catalytic hydrogenation of 8-nitrohalogenophenoxazin-3-ones 6a-c: general procedure
Nitro-1,2,3-trihalogeno-3H-phenoxazin-3-ones 6a-c were dissolved in a solvent mixture of EtOAc : MeOH (1:1) and either Pd/C 10% or PtO 2 (10% of the reactant mass) was added to the solution. The reaction mixture was then hydrogenated for 2 to 20 hours, the initial hydrogen pressure being set at 2.4bars. Hydrogenation was continued until the hydrogen pressure was steady, after which the catalyst was removed from the reaction mixture by filtration through Celite 451. The Celite cake was washed several times with methanol. MnO 2 (3 mol equivalent) was added to the clear solution and the resulting mixture stirred until no more amino-3-hydroxyphenoxazine was observed by TLC. The reaction mixture changed to a deep colour, ranging from blue to blue-violet, and was again filtered through Celite 451 to remove inorganic insoluble materials and the cake was washed several times with THF, until the filtrate was clear of colour. The solvent mixture was evaporated in vacuo and the residue was subjected to column chromatography on silica.
8-Amino-1,2,4-trifluoro-3H-phenoxazin-3-one (17a)
The title compound was prepared from 8-nitro-1,2,3-trifluoro-3H-phenoxazin-3-one 6a (0.38 g, 1.29 mmol) using Pd/C 10%. Elution used a gradient mixture of petroleum ether (60-80°C) 
Microbiological methods
Test compound 5-7 was dissolved in a small volume of N-methylpyrrolidone (100µL) and 
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